4 studies found for:    chTNT-1/B
Show Display Options
Rank Status Study
1 Completed Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
Condition: Glioblastoma Multiforme
Intervention: Drug: 131I-chTNT-1/B MAb (Cotara)
2 Completed Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: 131-I-chTNT-1/B MAB
3 Completed Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Intervention: Radiation: iodine I 131 monoclonal antibody TNT-1/B
4 Completed Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Radiation: iodine I 131 monoclonal antibody TNT-1/B

Indicates status has not been verified in more than two years